<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-cancers-12-00713">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pauls</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Badia</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Torres-Torronteras</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Ruiz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Permanyer</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Riveira-Muñoz</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Clotet</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Marti</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ballana</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Esté</surname>
    <given-names>J.A.</given-names>
   </name>
  </person-group>
  <article-title>Palbociclib, a selective inhibitor of cyclin-dependent kinase4/6, blocks HIV-1 reverse transcription through the control of sterile α motif and HD domain-containing protein-1 (SAMHD1) activity</article-title>
  <source>AIDS</source>
  <year>2014</year>
  <volume>28</volume>
  <fpage>2213</fpage>
  <lpage>2222</lpage>
  <pub-id pub-id-type="doi">10.1097/QAD.0000000000000399</pub-id>
  <pub-id pub-id-type="pmid">25036183</pub-id>
 </element-citation>
</ref>
